329 related articles for article (PubMed ID: 20078230)
1. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.
Lipskaia L; Chemaly ER; Hadri L; Lompre AM; Hajjar RJ
Expert Opin Biol Ther; 2010 Jan; 10(1):29-41. PubMed ID: 20078230
[TBL] [Abstract][Full Text] [Related]
2. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.
Kawase Y; Hajjar RJ
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):554-65. PubMed ID: 18665137
[TBL] [Abstract][Full Text] [Related]
3. Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.
Samuel TJ; Rosenberry RP; Lee S; Pan Z
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621141
[TBL] [Abstract][Full Text] [Related]
4. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b).
Greenberg B; Yaroshinsky A; Zsebo KM; Butler J; Felker GM; Voors AA; Rudy JJ; Wagner K; Hajjar RJ
JACC Heart Fail; 2014 Feb; 2(1):84-92. PubMed ID: 24622121
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for heart failure.
Greenberg B
J Cardiol; 2015 Sep; 66(3):195-200. PubMed ID: 25818479
[TBL] [Abstract][Full Text] [Related]
6. Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart.
Cutler MJ; Wan X; Plummer BN; Liu H; Deschenes I; Laurita KR; Hajjar RJ; Rosenbaum DS
Circulation; 2012 Oct; 126(17):2095-104. PubMed ID: 23019291
[TBL] [Abstract][Full Text] [Related]
7. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.
Lyon AR; Bannister ML; Collins T; Pearce E; Sepehripour AH; Dubb SS; Garcia E; O'Gara P; Liang L; Kohlbrenner E; Hajjar RJ; Peters NS; Poole-Wilson PA; Macleod KT; Harding SE
Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):362-72. PubMed ID: 21406682
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl-Prolyl Isomerase 1 Regulates Ca
Sacchi V; Wang BJ; Kubli D; Martinez AS; Jin JK; Alvarez R; Hariharan N; Glembotski C; Uchida T; Malter JS; Yang Y; Gross P; Zhang C; Houser S; Rota M; Sussman MA
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018025
[TBL] [Abstract][Full Text] [Related]
9. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Papolos A; Frishman WH
Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057
[TBL] [Abstract][Full Text] [Related]
10. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.
del Monte F; Williams E; Lebeche D; Schmidt U; Rosenzweig A; Gwathmey JK; Lewandowski ED; Hajjar RJ
Circulation; 2001 Sep; 104(12):1424-9. PubMed ID: 11560860
[TBL] [Abstract][Full Text] [Related]
11. Cardiac SERCA2A/B: therapeutic targets for heart failure.
Shareef MA; Anwer LA; Poizat C
Eur J Pharmacol; 2014 Feb; 724():1-8. PubMed ID: 24361307
[TBL] [Abstract][Full Text] [Related]
12. SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope.
Sikkel MB; Hayward C; MacLeod KT; Harding SE; Lyon AR
Br J Pharmacol; 2014 Jan; 171(1):38-54. PubMed ID: 24138023
[TBL] [Abstract][Full Text] [Related]
13. SERCA2a: a key protein in the Ca
Zhihao L; Jingyu N; Lan L; Michael S; Rui G; Xiyun B; Xiaozhi L; Guanwei F
Heart Fail Rev; 2020 May; 25(3):523-535. PubMed ID: 31701344
[TBL] [Abstract][Full Text] [Related]
14. SERCA2a: a prime target for modulation of cardiac contractility during heart failure.
Park WJ; Oh JG
BMB Rep; 2013 May; 46(5):237-43. PubMed ID: 23710633
[TBL] [Abstract][Full Text] [Related]
15. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.
Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Desai AS; Barnard D; Bouchard A; Jaski B; Lyon AR; Pogoda JM; Rudy JJ; Zsebo KM
Lancet; 2016 Mar; 387(10024):1178-86. PubMed ID: 26803443
[TBL] [Abstract][Full Text] [Related]
16. Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca
Gorski PA; Jang SP; Jeong D; Lee A; Lee P; Oh JG; Chepurko V; Yang DK; Kwak TH; Eom SH; Park ZY; Yoo YJ; Kim DH; Kook H; Sunagawa Y; Morimoto T; Hasegawa K; Sadoshima J; Vangheluwe P; Hajjar RJ; Park WJ; Kho C
Circ Res; 2019 Apr; 124(9):e63-e80. PubMed ID: 30786847
[TBL] [Abstract][Full Text] [Related]
17. Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.
Lipskaia L; Hadri L; Lopez JJ; Hajjar RJ; Bobe R
Curr Vasc Pharmacol; 2013 Jul; 11(4):465-79. PubMed ID: 23905641
[TBL] [Abstract][Full Text] [Related]
18. Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia.
Xin W; Li X; Lu X; Niu K; Cai J
Acta Cardiol; 2011 Feb; 66(1):57-64. PubMed ID: 21446381
[TBL] [Abstract][Full Text] [Related]
19. [Modification of sarco-endoplasmic reticulum Ca(2 +) -ATPase in the failing cardiomyocyte].
Ikeda Y
Clin Calcium; 2013 Apr; 23(4):535-42. PubMed ID: 23545743
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of sarcoplasmic reticulum calcium ATPase induced hemodynamic and proteomic changes in a dog model of heart failure].
Fu ZQ; Li XY; Liu XH; Sun S; Liu T; Mi YF; Zhou SA; Ye WH; Wang QS
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):260-5. PubMed ID: 19099986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
